Stalemating a clever opportunist: Lessons from murine cytomegalovirus

Human Immunology

Volumn 65, Issue 5, 2004, Pages 446-455

  Reddehase, Matthias J ^a   Simon, Christian O ^a   Podlech, Jürgen ^a   Holtappels, Rafaela ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

antigen presentation; Cytomegalovirus; immune evasion; immune surveillance; immunodominance

Indexed keywords

GLYCOPROTEIN; HLA ANTIGEN CLASS 1; IMMUNOEVASIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; CELL SURFACE; CELLULAR IMMUNITY; COMPLEX FORMATION; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; EFFECTOR CELL; HISTOCOMPATIBILITY COMPLEX; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOMODULATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; NATURAL KILLER CELL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 2542498602     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.02.024     Document Type: Article

References (32)

1. Reddehase M.J. Antigens and immunoevasins opponents in cytomegalovirus immune surveillance. Nat Rev Immunol. 2:2002;831
2. Yewdell J.W., Bennink J.R. Immunodominance in major histocompatibility complex class-I restricted T lymphocyte responses. Annu Rev Immunol. 17:1999;51
3. Yewdell J.W., Hill A.B. Viral interference with antigen presentation. Nat Immunol. 3:2002;1019
4. Wagner M., Gutermann A., Podlech J., Reddehase M.J., Koszinowski U.H. MHC class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med. 196:2002;805
5. Hengel H., Brune W., Koszinowski U.H. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol. 6:1998;190
6. Ziegler H., Muranyi W., Burgert H.G., Kremmer E., Koszinowski U.H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 19:2000;870
7. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1999;1081
8. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:1997;685
9. Kavanagh D.G., Koszinowski U.H., Hill A.B. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J Immunol. 167:2001;3894
10. Reddehase M.J. The immunogenicity of human and murine cytomegaloviruses. Curr Opin Immunol. 12:2000;390
11. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu Rev Immunol. 18:2000;861
12. Holtappels R., Grzimek N.K.A., Simon C.O., Thomas D., Dreis D., Reddehase M.J. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol. 76:2002;6044
13. Christinck E.R., Luscher M.A., Barber B.H., Williams D.B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (London). 352:1991;67
14. Sykulev Y., Joo M., Vturina I., Tsomides T.J., Eisen H.N. Evidence that a single peptide-MHC complex on a target cell can elicit a cytotoxic T cell response. Immunity. 4:1996;565
15. Reddehase M.J., Fibi M.R., Keil G.M., Koszinowski U.H. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J Virol. 60:1986;1125
16. Del Val M., Münch K., Reddehase M.J., Koszinowski U.H. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell. 58:1989;305
17. Kavanagh D.G., Gold M.C., Wagner M., Koszinowski U.H., Hill A.B. The multiple immune-evasion genes of murine cytomegalovirus are not redundant m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med. 194:2001;967
18. Gold M.C., Munks M.W., Wagner M., Koszinowski U.H., Hill A.B., Fling S.P. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL, but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. J Immunol. 169:2002;359
19. b-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol. 77:2003;301
20. Thäle R., Szepan U., Hengel H., Geginat G., Lucin P., Koszinowski U.H. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol. 69:1995;6098
21. Krmpotic A., Messerle M., Crnkovic-Mertens I., Polic B., Jonjic S., Koszinowski U.H. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med. 190:1999;1285
22. Holtappels R., Podlech J., Pahl-Seibert M.-F., Jülch M., Thomas D., Simon C.O., Wagner M., Reddehase M.J. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med. 199:2004;131
23. Kärre K. Clever, cleverer, cleverest. Nat Immunol. 3:2002;505
24. Holtappels R., Thomas D., Podlech J., Geginat G., Steffens H.P., Reddehase M.J. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. J Virol. 74:2000;1871
25. d epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide. J Immunol. 167:2001;1515
26. Hengel H., Lucin P., Jonjic S., Ruppert T., Koszinowski U.H. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol. 68:1994;289
27. Hengel H., Reusch U., Geginat G., Holtappels R., Ruppert T., Hellebrand E., Koszinowski U.H. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol. 74:2000;7861
28. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat Reviews Immunol. 1:2001;126
29. Podlech J., Holtappels R., Wirtz N., Steffens H.-P., Reddehase M.J. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J Gen Virol. 79:1998;2099
30. Krmpotic A., Busch D.H., Bubic I., Gebhardt F., Hengel H., Hasan M., Scalzo A.A., Koszinowski U.H., Jonjic S. MCMV glycoprotein gp40 confers virus resistance to CD8+ T lymphocytes and NK cells in vivo. Nat Immunol. 3:2002;529
31. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med. 197:2003;1245
32. Podlech J., Holtappels R., Grzimek N.K.A., Reddehase M.J. Animal models murine cytomegalovirus. Meth Microbiol. 32:2002;493